OPK Opko Health Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: OPK

Price (delayed)

$1.355

Market cap

$1.05B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.46

Enterprise value

$1.18B

Opko Health Inc. is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and ...

Highlights
Opko Health's quick ratio has increased by 15% from the previous quarter and by 10% YoY
Opko Health's gross margin has decreased by 13% YoY but it has increased by 2.9% from the previous quarter
The gross profit has plunged by 50% YoY and by 15% from the previous quarter
The company's revenue fell by 43% YoY and by 18% QoQ
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.opko.com
Peers: JNJ ABT REGN ALNY

Key stats

What are the main financial stats of OPK
Market
Shares outstanding
772.65M
Market cap
$1.05B
Enterprise value
$1.18B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.67
Price to sales (P/S)
0.97
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.18
Earnings
Revenue
$1B
EBIT
-$379.85M
EBITDA
-$271.19M
Free cash flow
-$117.82M
Per share
EPS
-$0.46
Free cash flow per share
-$0.16
Book value per share
$2.02
Revenue per share
$1.4
TBVPS
$1.04
Balance sheet
Total assets
$2.17B
Total liabilities
$605.61M
Debt
$286.55M
Equity
$1.56B
Working capital
$181.05M
Liquidity
Debt to equity
0.18
Current ratio
1.85
Quick ratio
1.31
Net debt/EBITDA
-0.49
Margins
EBITDA margin
-27%
Gross margin
28.7%
Net margin
-32.7%
Operating margin
-22.5%
Efficiency
Return on assets
-14.5%
Return on equity
-20.1%
Return on invested capital
-53.4%
Return on capital employed
-19.4%
Return on sales
-37.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

OPK stock price

How has the Opko Health stock price performed over time
Intraday
-0.37%
1 week
-0.37%
1 month
27.83%
1 year
-62.36%
YTD
8.4%
QTD
8.4%

Financial performance

How have Opko Health's revenue and profit performed over time
Revenue
$1B
Gross profit
$288.22M
Operating income
-$226.25M
Net income
-$328.41M
Gross margin
28.7%
Net margin
-32.7%
The gross profit has plunged by 50% YoY and by 15% from the previous quarter
The company's revenue fell by 43% YoY and by 18% QoQ
The net margin has decreased by 26% QoQ
OPK's operating margin is down by 17% since the previous quarter

Growth

What is Opko Health's growth rate over time

Valuation

What is Opko Health stock price valuation
P/E
N/A
P/B
0.67
P/S
0.97
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.18
Opko Health's EPS has decreased by 2.2% from the previous quarter
The P/B is 44% below the 5-year quarterly average of 1.2 and 33% below the last 4 quarters average of 1.0
Opko Health's equity has decreased by 7% YoY and by 4.1% QoQ
The company's revenue fell by 43% YoY and by 18% QoQ
The P/S is 39% below the 5-year quarterly average of 1.6 and 19% below the last 4 quarters average of 1.2

Efficiency

How efficient is Opko Health business performance
OPK's ROIC is down by 37% since the previous quarter
Opko Health's ROS has decreased by 35% from the previous quarter
The ROA has contracted by 7% from the previous quarter
The ROE has decreased by 5% QoQ

Dividends

What is OPK's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for OPK.

Financial health

How did Opko Health financials performed over time
Opko Health's current ratio has decreased by 26% YoY but it has increased by 19% from the previous quarter
Opko Health's quick ratio has increased by 15% from the previous quarter and by 10% YoY
The debt is 82% lower than the equity
The debt to equity is up by 20% year-on-year and by 6% since the previous quarter
The debt has increased by 16% YoY and by 3.7% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.